The CxO's Case for Autonomous RCM
Register to view
Fill in the form below to watch the video.
About this recording
Revenue cycle leaders know the problem. They've seen the pilots. The harder question is how to build the board-level case for AI that executes rather than assists — and sustain it through every budget cycle.
Rick Hardy brings decades of RCM leadership to the most consequential decision in healthcare finance today.
Who should attend
Revenue cycle leaders, CFOs, and other C-suite executives who have to build and defend the case for autonomous RCM to a board. Relevant to anyone whose AI investment has to survive repeated budget cycles.
Who you'll hear from
Rick Hardy
Optum Insight
Ex-CEO
How AI in RCM Is Being Deployed in Practice, Not in Theory
McLaren Healthcare is not running a pilot. A look at what autonomous RCM deployment actually looks like inside a large health system, including what was harder than expected.
The AI Opportunity in Utilization Management
Prior authorization is under regulatory pressure and operational strain. Where AI is delivering genuine value in utilization management — and what separates successful deployments from those that create new compliance and clinical risk.
Buyer's Guide to Healthcare Autonomy Platforms
A CHIME-endorsed framework for evaluating platforms that claim to execute autonomous workflows — and the questions that separate genuine context infrastructure from context-poor automation dressed up as autonomy.